Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis

20251 citationsJournal Articlegreen Open Access

Authors

Catherine Zhu · McGill University

Katya Peri · McGill University

Catherine Silotch · McGill University

Connor Prosty · McGill University

Hessah BinJadeed · McGill University

Anastasiya Muntyanu · University of Toronto

Mahalakshmi Nagarajan ·

Abstract

The results of this systematic review and IPD meta-analysis suggest that BTX injections appear to be a safe and effective adjunct for refractory digital ischemia in systemic sclerosis. Prospective trials are needed to confirm long-term effectiveness and standardize administration protocols.

Topics & Keywords

Systemic Sclerosis and Related Diseases Dermatologic Treatments and Research Diagnosis and Treatment of Venous Diseases

Publication Details

Published in: JAMA Dermatology

Volume 162, Issue 1, pp. 47-47

DOI: 10.1001/jamadermatol.2025.4929

Field-Weighted Citation Impact: 1.54

Command Palette

Botulinum Toxin for Refractory Digital Ischemia and Ulcers in Systemic Sclerosis

Authors

Abstract

Topics & Keywords

Publication Details